⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28091199 | 0.78 | LMNA (0.41) | — | |
| SCHEMBL2270900 | 0.77 | — | — | |
| Water SCHEMBL28334213 | 0.76 | LMNA (0.39) | — | |
| SCHEMBL15234030 | 0.73 | — | — | |
| SCHEMBL12522115 | 0.73 | — | — | |
| SCHEMBL29008148 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL3915135 | 0.71 | — | — | |
| SCHEMBL4731825 | 0.71 | — | — | |
| SCHEMBL27997171 | 0.71 | — | — | |
| SCHEMBL10804839 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8772268-B2 | Bisphosphonamidate prodrugs and uses thereof | THE JOHNS HOPKINS UNIVERSITY (US) | 2014-07-08 | — | — | US | disclosed |
| US-20130090311-A1 | BISPHOSPHONAMIDATE PRODRUGS AND USES THEREOF | THE JOHNS HOPKINS UNIVERSITY (US) | 2013-04-11 | — | — | US | disclosed |
| WO-2011139791-A2 | BISPHOSPHONAMIDATE PRODRUGS AND USES THEREOF | THE JOHNS HOPKINS UNIVERSITY (US) | 2011-11-10 | — | — | WO | disclosed |
| US-7173020-B2 | Phosphoramidates and methods therefor | PURDUE RESEARCH FOUNDATION (US) | 2007-02-06 | — | — | US | disclosed |
| EP-1268493-B1 | PHOSPHORAMIDATE PRODRUGS | PURDUE RESEARCH FOUNDATION (US) | 2006-02-15 | — | — | EP | disclosed |
| US-20050171060-A1 | Phosphoramidates and methods therefor | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2005-08-04 | — | — | US | disclosed |
| US-6903081-B2 | Phosphoramidates and methods therefor | PURDUE RESEARCH FOUNDATION (US) | 2005-06-07 | — | — | US | disclosed |
| EP-1268493-A1 | PHOSPHORAMIDATE PRODRUGS | PURDUE RESEARCH FOUNDATION (US) | 2003-01-02 | — | — | EP | disclosed |
| US-20020004594-A1 | Phosphoramidates and methods therefor | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2002-01-10 | — | — | US | disclosed |
| WO-2001074827-A1 | PHOSPHORAMIDATE PRODRUGS | PURDUE RESEARCH FOUNDATION (US) | 2001-10-11 | — | — | WO | disclosed |